Lupin Ltd - Company Profile
Powered by
All the data and insights you need on Lupin Ltd in one report.
- Save hours of research time and resources with
our up-to-date Lupin Ltd Strategy Report
- Understand Lupin Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Lupin Ltd (Lupin) undertakes the manufacture and marketing of generic and branded pharmaceutical products, and active pharmaceutical ingredients (APIs). The company focuses on therapeutic areas such as generics, biosimilars, specialty, over-the-counter, active pharmaceutical ingredients, global institutional business, tech-driven offerings. It is one of the leading and fasting growing companies.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
The company focuses its research and development programs on the discovery of new biosimilars in the areas of pain, inflammation, metabolic and endocrine diseases, auto immune diseases, central nervous system disorders, oncology and infectious diseases. These advanced drug delivery platforms enable the company to produce value added generic and branded pharmaceuticals. The company has a strong portfolio of products for including 463 ANDAs and four NDAs which have been approved by the US FDA. The company has seven research facilities in India: Pune & Aurangabad, U.S; New Jersey & Florida, LATAM; Mexico & Brazil Europe; Netherlands. The company has 911 active patents. It has 1,400 employees for R&D activities. In FY2023 Lupin’s expenditure on R&D amounted to INR12,800.1 million, which as a percentage stood at 7.69%.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward